PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications.
Zhu H, Wei M, Xu J, Hua J, Liang C, Meng Q, Zhang Y, Liu J, Zhang B, Yu X, Shi S.
Zhu H, et al. Among authors: zhang b, zhang y.
Mol Cancer. 2020 Mar 2;19(1):49. doi: 10.1186/s12943-020-01167-9.
Mol Cancer. 2020.
PMID: 32122376
Free PMC article.
Review.